Reducing Morbidity and Mortality by enhancing the “Golden Hour” through innovation.
The mission of Advanced Trauma Specialties, LLC is to make a positive impact in overall patient outcomes and provider care by offering cutting edge medical/tactical solutions for trauma and specialty providers." advanced Trauma Specialties is a value driven company guided by the principals of strong customer service, advocacy for public safety, desire to provide for innovative patient care, research and quality training. the products represented by advanced Trauma Specialties are truly believed to revolutionize patient outcomes in trauma and specialty care situations.
Advanced Trauma Specialties, LLC was formed to provide national/international marketing, sales and education, of the CELOX™ product line (specifically RAPID) on behalf of MedTrade, Ltd. (The Manufacturer).
Our company is young; however, our principal has a very long and distinguished background as First Responder (EMS), Administrator, Educator, In-Hospital and Urgent Care Provider. We hope to translate this experience to both the general community and our respective peer communities (LEO, EMS, Fire Emergency Departments) to educate and bring a superior product to the marketplace.
"One of our critical missions is to educate all First Responders about the successful use of hemostatic agents and their ability to reduce morbidity and mortality in critical incidents, occurring within our own peer groups, by providing (Self-Aid/Buddy-Aid). As well as, to enhance the confidence, knowledge, level of care offered and earlier definitive intervention by those First Responders to the general public in their critical times of need." We believe our product to be a cost effective means of saving many lives and we are offering a new philosophy on treatment of one of the leading causes of death, exsanguinations.
Researchers from NAMRU-SA, (in their 2012 study), using the CoTCCC standard model of a femoral artery injury, reports that CELOX™ line of products is the Best in Class Hemostatic Agent with a: 90% Survival Rate, Lowest total blood loss, Highest proportion of achieving hemostasis, and Longest period of hemostasis. This can only translate into "Saving Blood, Saving Time, and Saving Lives."